Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Testicular Cancer Detected Using a Simple Sperm Sample

By LabMedica International staff writers
Posted on 07 Jun 2012
A team of scientists has found markers for testicular cancer. More...
This will enable physicians to detect the disease before it develops, via a simple sperm sample.

Discovery of the markers has made it possible to see from a simple sperm sample whether a patient will develop testicular cancer. Thus, treatment can be provided for men who would otherwise not have found the disease until much later, and a more gentle treatment can begin at an earlier stage.

This is beneficial particularly for men with testicular cancer, because they usually discover the disease in their 20s or 30s, which means they have a long life ahead of them with possible late complications from cancer treatment.

Men with poor sperm quality, in particular, those who consult the hospital because of fertility problems, are being examined to detect possible early stages of testicular cancer. According to the investigators, poor sperm quality and predisposition to testicular cancer can be traced all the way back to fetal germ-cell development.

A research team at Rigshospitalet (Copenhagen, Denmark) has developed a special scanning microscope and software, which can analyze sperm samples. The discovery has attracted much attention from colleagues abroad.

"So far, we are cooperating with researchers in Norway, Germany, and Poland, who can make use of our discovery in different ways. The equipment is expensive, so to begin with we are helping by analyzing their samples, but in the long term we would like to join up with a company that can supply a total kit for use by other researchers and physicians in different European countries," said Kristian Almstrup from the department of growth and reproduction at Rigshospitalet.

Previously, suspicion of testicular cancer meant that a patient was subjected to one or two painful biopsies, and despite a 95% survival rate, the testicular cancer diagnosis meant having to go through treatment that could be extremely hard on the body.

Related Links:
Rigshospitalet




Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.